Griet Nuytinck
Angel Investor
Griet Nuytinck is a seed investor focused on Medical and Life Science. Griet Nuytinck is founder of Anacura.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Griet Nuytinck invests in
Stages Griet Nuytinck invests in
Countries Griet Nuytinck invests in
Investment Focus
Industry
- Medical 1 (100%)
- Life Science 1 (100%)
- Biotechnology 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
4Tissue
|
4Tissue is a research and clinical development firm that develops solutions to solve the limitations of cell-based therapies. | $2.2M / Seed / Oct 23, 2024 |
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Griet Nuytinck invest in?
Griet Nuytinck invests primarily in Medical, Life Science and Biotechnology startups, most often at Seed stage. Most of the 1 investments tracked by Shizune back companies in Belgium. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Griet Nuytinck last invest?
The most recent investment recorded for Griet Nuytinck closed in Oct 2024. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
